Pharma Equity Group A/S
CSE:PEG
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Tadiran Group Ltd
TASE:TDRN
|
IL |
|
Shanghai Action Education Technology Co Ltd
SSE:605098
|
CN |
|
Medcom Tech SA
MAD:MED
|
ES |
|
A G Barr PLC
LSE:BAG
|
UK |
|
G
|
Guinness VCT PLC
LSE:GVCT
|
UK |
|
AXIS Capital Holdings Ltd
NYSE:AXS
|
BM |
|
Country Garden Holdings Co Ltd
OTC:CTRYY
|
CN |
|
Anexo Group PLC
LSE:ANX
|
UK |
|
BOC International China Co Ltd
SSE:601696
|
CN |
|
B
|
Bhang Inc
CNSX:BHNG
|
CA |
|
I
|
Imagine Lithium Inc
XTSX:ILI
|
CA |
|
N
|
Nixu Oyj
OMXH:NIXU
|
FI |
|
Eurobio Scientific SA
PAR:ALERS
|
FR |
Pharma Equity Group A/S
Intangible Assets
Pharma Equity Group A/S
Intangible Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
Pharma Equity Group A/S
CSE:PEG
|
Intangible Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Jeudan A/S
CSE:JDAN
|
Intangible Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Copenhagen Capital A/S
CSE:CPHCAP ST
|
Intangible Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
P
|
Prime Office A/S
CSE:PRIMOF
|
Intangible Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Fast Ejendom Danmark A/S
CSE:FED
|
Intangible Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
E
|
EgnsINVEST Ejendomme Tyskland A/S
CSE:EGNETY
|
Intangible Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Pharma Equity Group A/S
Glance View
Pharma Equity Group A/S is a property company, which engages in the investment on real estates. The firm's purpose is, without geographical limitation, to be a holding company for companies with life science activities and to invest in shares admitted to trading on a regulated market place or multilateral trading facility and unlisted capital shares as determined by the board of directors in order to achieve long-term value growth while observing appropriate risk diversification as well as other related businesses.